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Qena governorateAbstract Backgrounds: COPD is a common health problem with increasing prevalence all over
the world. It is underdiagnosed with very few studies about its prevalence in developing countries.
Hence it is important to know and evaluate the prevalence of this disease in our community.
Patients and methods: A prospective cross sectional study was performed in the southern area of
Egypt where 2400 subjects above 40 years old agreed to participate and filled questionnaires that
included demographic data and CAT questionnaire. Suspicious cases according to symptoms,
smoking status and positive CAT score were performed spirometry and confirmed cases were
defined as FEV1/FVC post bronchodilator <0.70.
Results: There was 25% of studied population resident in urban and 75% in rural areas with
1675 (70%) being males and 725 (30%) females. There was 37.5% in age group 50–59 and
26.4% above 60 years. In the confirmed COPD cases the main symptom was dyspnea 93.7%, fol-
lowed by cough and expectoration 67.8%, and wheezy chest 52.5%. There was 32% of cases having
CAT scores <10 and 68% was >10. Reflux was the main comorbidity with 75% followed by dia-
betes 31.2%, heart diseases 24.3%, and hypertension 15%. The presentations of suspicious COPD
cases were 495 cases, 20.6%; by comparing the confirmed and not confirmed cases there were sig-
nificant differences between both groups in cough, expectoration, dyspnea, wheeze, CAT score and
comorbidity P value <0.0001 except hypertension and depression. 42.5% of COPD confirmed
cases were categorized into stage B followed by stage D (25.6%) then stage C (20.6%) and stage
A 11.3%. The prevalence rate of COPD was 6.6% with the highest prevalence in age above 60 years
9.2% with significant P value <0.0001 between different age groups. Prevalence in urban area was
7.6% and in rural area was 6.3% without significant difference. As regards smoking habits the high
prevalence was in X smoker 16.3% followed by current smoker 8.6% with significant P value
<0.0001. There is high prevalence rate in cases exposed to biomass fuel 13.6% versus 5.8% in
not exposed cases with significant P value <0.0001.rculosis.
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Chronic obstructive pulmonary disease (COPD) is a common
community problem and considered an essential cause of mor-
bidity and mortality in both developed and developing coun-
tries. COPD is expected to be the third leading cause of
death by 2020 [1,2]. There were no previous studies conducted
to show the prevalence of COPD in Qena governorate. So, this
study was considered as a nucleus study for this purpose. Esti-
mation of COPD prevalence in some regions may vary due to
underutilization of spirometry and inadequate diagnosis.
The diagnosis of COPD is based on symptoms, the presence
of risk factors and spirometry. Smoking is an important cause
for the development of COPD. Exposure to biomass fuel is an
important risk factor in nonsmoker and female population.
Although COPD develops in only about 10–15% of smokers,
studies have shown that 4 of 5 patients with COPD are either
current or former smokers [3,4]. There is under diagnosis of
COPD which can result in under treatment as less than one-
third of patients in the MENA region receive appropriate
treatment for COPD [5].
A study showed that less than 6% of the people informed
having COPD [6]. This likely reflects the widespread under
recognition and under diagnosis of COPD as well as the fact
that those with Stage I: Mild COPD may have no symptoms,
or mild symptoms and not perceived by individuals or their
health care providers as abnormal and possibly indicative of
early COPD [7]. By contrast, data from prevalence surveys car-
ried out in multiple countries, using spirometry, estimate that
up to about one-quarter of adults aged >40 years may have
airflow limitation diagnosed as mild COPD or higher [8,9].
In this regard, there is a need for a field study survey to esti-
mate the prevalence of COPD in our locality.
Subjects and methods
A cross sectional study was done in the south Upper Egypt,
Qena governorates by chest department, South Valley Univer-
sity in collaboration with community and public health depart-
ment, Sohag University. The total area of this governorate
covers 10,798 Km2 representing 1.1% of the republic area.
According to preliminary results of the 2014 census, the popu-
lation is about 3 million, 21.4% of them live in urban areas
and 78.6% in rural areas. Qena area included two cities and
eleven districts. Qena and Nag Hammadi are considered urban
areas. Qena city is the capital of the governorate. It is situated
on the east bank of the Nile. It is most famous for its proximity
to the ruins of Dendra. The population is 230.392. Nag Ham-
madi is located on the west bank of the Nile. It is an industrial
city as sugar and aluminum are produced there. It has a pop-
ulation of about 30,000. The 11 districts are considered as rural
areas, which are distributed around Nile, where most of people
are farmers.The sample size was calculated using EPI tools for calculat-
ing sample size for single proportion [10]. Based on an
expected prevalence of 7% among adults, with 2 percentage
point error and 95% confidence interval, allowing for a 10%
refusal to participate, 626 people were needed to be involved
in the study. The study was conducted over a one year period
from June 1, 2014 to the prevalence day which is May 31, 2015.
Sampling methodology
A simple random sample of 10 study areas was chosen from
the governorate. According to the geographic location we
selected 3 districts randomly from eleven districts, and then
we chose two villages from each district, that is Nagada from
the west, Qift from the east, Dishenna from the north with a
total of 6 villages considered as rural population. Second we
selected 2 areas from each Qena and Nag Hammadi with a
total 4 urban areas by a simple random technique. A system-
atic random sample of households in the 10 areas was then
taken by selecting every third household in every 10 field areas.
If individuals did not agree for the test, we replaced them with
the family next door.
Data collection
Subjects fulfilling the screening criteria of more than 40 years
old were invited to complete a more detailed questionnaire
on the disease to assess the severity of COPD (CAT question-
naire) [11]. The questionnaire was in classical Arabic easily
understandable. Written informed consent was obtained from
all participants. There is no gift to invited subjects. Patients
with COPD suspicions based on the symptoms and clinical
presentation and CAT scoring above zero were asked to
undergo spirometry.
Pilot study
A pilot study has been carried out to test the validity of the
questionnaire and checklist and to carry out the necessary
developments and corrections (3 weeks duration). Then the
final questionnaire and checklist were used in the implementa-
tion of the study.
The survey team comprised of 5 social workers who used
the screening questionnaire headed by 2 chest physicians
who confirmed the diagnosis by reusing the screening question-
naire and performing spirometry. The team received 3 weeks
of training on how to carry out the protocol before starting
the study. The study was approved by the ethics committee
of our faculty of medicine.
The total number of the interviewed subjects was 2500.
Only 2400 completed the questionnaire and are included in
the analysis: 600 in the urban area and 1800 in the rural area
according to population distribution. The causes for exclusion
Table 1 Socio-demographic characteristics of the studied
cases.
Socio-demographic characters Number %
Age
40–49 865 36.04
50–59 900 37.50
>60 635 26.46
Gender
Males 1675 69.79
Females 725 30.21
Residence
Urban 600 25.00
Rural 1800 75.00
Occupation
Farmer 905 37.71
Worker 435 18.13
Employee 315 13.13
Retired 110 4.58
House wife 635 26.46
Smoking status
Current smoker 1210 50.42
X-smoker 165 6.88
Never smoker 1025 42.71
Biomass fuel exposure 242 10.08
Previously diagnosed COPD 12 7.50
Family history of chest disease 86 3.58
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people); subject request, and fail to perform spirometry for
individuals suspicious of having COPD (60 people).
Those people have been interviewed and subjected to the
following:
1. Filling the questionnaires of the history taking and eight
items of CAT score and divided into low symptoms score
<10 and high score P10.
2. General and local examination; Information about age; sex,
smoking habits either cigarette or goza, exposure to
biomass fuels; occupation; comorbidities; medication;
family history of lung disease; and whether the person
was previously diagnosed with COPD were collected in a
face-to-face interview. Occupation also was reported to
the interviewing physician. Participants were also asked to
report symptoms of wheeze, and dyspnea with either yes
or No.
3. Pulmonary function test by the portable spiro-sift SP-5000
Fukuda DENSHI, Japan was done for suspicious cases of
having any symptoms suggestive of COPD. Spirometry
was performed according to the American Thoracic Society
(ATS) criteria [12] by trained physicians using a spirometer
with subjects in a seated position. Two measurements were
taken, one before and after two puffs of salbutamol
(400 lg) using a metered-dose inhaler. COPD was defined
as a ratio of post-bronchodilator-predicted forced expira-
tory volume in the 1st second to forced vital capacity of less
than 0.70 (FEV1/FVC <0.70). The severity of function
impairment was categorized by GOLD as: mild, FEV1
P80% of predicted; moderate, FEV1 <80–50%; severe,
FEV1 <50–30%; very severe, FEV1 <30% [3].
Statistical analysis
Data were analyzed using STATA intercooled version 12.1.
Quantitative data were represented as mean and standard devi-
ation. Data were analyzed using a paired t-test to compare
means of the result of the test pre and post bronchodilator.
Quantitative data and prevalence of COPD in different groups
were presented as number and percentage and compared using
either Chi square test. P value was considered significant if it
was less than 0.05.Results
2400 subjects included in the study filled the questionnaire with
25% in urban and 75% in rural area with 1675 (70%) males
and 725 (30%) females. 37.5% was in the age group between
50 and 59 and 26.4% was above 60 years old. The main occu-
pation was farmer 37.7% among the studied population fol-
lowed by house wife 26.4%. 50.4% were currently smokers
and 42.7% was never smoker. There was 10.8% exposed to
biomass fuel, 7.5% was previously diagnosed COPD and
maintained on medication and 3% had family history of chest
diseases as shown in (Table 1).
The clinical presentations of suspicious cases of COPD
were (495 cases, 20.6%) comparing the confirmed and not con-
firmed cases by spirometry. There were statistically significant
differences between both groups among all parameters excepthypertension and depression. In the confirmed COPD cases
the main symptom was dyspnea 93.7%, followed by cough
and expectoration 67.8%, wheezy chest 52.5%. There was
31% of cases with CAT score <10 and 68% was >10. Reflux
was the main comorbidity 75% followed by diabetes 31.2%,
heart diseases 24.3%, hypertension 15%, and depression
10.6% as presented in (Table 2).
There were no statistically significant differences between
all parameters as regards mean ± SD of all values except for
FEV1 with P value 0.02. In confirmed COPD cases as regards
FEV1 there was 54% in stage 2 and 24% in stage 3, 15% in
stage 4 and only 7% in stage 1 as shown in (Tables 3 and 4).
Using CAT scores of less and more than 10 and FEV1 less
or more than 50% the main COPD confirmed cases were cat-
egorized into stage B 42.5% followed by stage D 25.6% then
stage C 20.6% and stage A 11.3% as in (Table 5).
The prevalence rate of COPD among the studied popula-
tion was 6.6%. The highest prevalence was in age above
60 years old 9.2% with significant P value <0.0001 between
different age groups. Male gender had more prevalence than
female gender with insignificant difference. Prevalence in
urban area was 7.6% and in rural area was 6.3% with no sig-
nificant difference. Highest prevalence was in retired popula-
tion 10% followed by worker 7.1% with insignificant
difference between different occupations. As regards smoking
habits the high prevalence was in X smoker 16.3% followed
by current smoker 8.6% with significant P value <0.0001.
There is a high prevalence rate in cases exposed to biomass fuel
13.6% versus 5.8% in cases not exposed with significant
P value <0.0001 as shown in (Table 6).
Table 2 Clinical presentations of studied suspicious COPD cases and comparing confirmed with not confirmed cases.
Variables Suspicious COPD P value
Confirmed COPD (160) Not confirmed COPD (335) Total (495)
No. % No. % No. %
Cough and expectoration 123 76.80 181 54.03% 304 61.41 <0.0001
Dyspnea 150 93.75 34 10.15% 184 37.17 <0.0001
Wheeze 84 52.50 50 15.38 134 27.63 <0.0001
CAT score <0.0001
<10 51 31.87 280 80.46 331 66.87
>10 109 68.13 35 16.42 164 33.13
Co-morbidity
Hypertension 24 15.00 68 20.30 92 18.59 0.16
Diabetes 50 31.25 54 16.12 104 21.01 <0.0001
Heart disease 39 24.38 18 5.37 57 11.52 <0.0001
Reflux 120 75.00 17 5.07 137 27.68 <0.0001
Depression 17 10.63 20 5.97 37 7.40 0.07
Table 3 Mean value of respiratory functions data of con-
firmed cases.
Mean value
parameters
Pre-
bronchodilator
test
Post-
bronchodilator
test
P
value
FVC % 81.3 ± 9.5 82.1 ± 9.7 0.35
FEV1 % 51.2 ± 12.5 53.8 ± 13.6 0.02
FEV1/FVC 62.9 ± 10.3 64.63 ± 12.5 0.10
FEV 25–75 % 56.1 ± 13.8 57.2 ± 15.2 0.42
PEF % 65.5 ± 16.7 66.4 ± 19.4 0.60
Table 4 Severity of COPD according to FEV1in the studied
confirmed cases.
Variables No. %
Stage 1 12 7.50
Stage 2 86 53.75
Stage 3 39 24.38
Stage 4 23 14.37
Table 5 Staging of COPD confirmed cases according to CAT
scores and FEV1 more or less than 50%.
Variables No. %
Stage A 18 11.3
Stage B 68 42.5
Stage C 33 20.6
Stage D 41 25.6
Table 6 Relation between prevalence rates of confirmed
COPD to socio-demographic data of studied populations.
Socio-
demographic
characters
Total
Number
Number
of
confirmed
COPD
Prevalence
of COPD
(%)
P value
Over all 2400 160 6.67
Age
40–49 865 35 4.05
50–59 900 70 7.78 <0.0001
>60 635 59 9.29
Gender
Males 1675 118 7.04 0.26
Females 725 42 5.79
By residence
Urban 600 46 7.67 0.26
Rural 1800 114 6.33
Occupation
Farmer 905 58 6.41
Worker 435 31 7.13 0.61
Employee 315 18 5.71
Retired 110 11 10.00
House wife 635 42 6.61
Smoking status
Current smoker 1210 104 8.60 <0.0001
X-smoker 165 27 16.36
Never smoker 1025 29 2.83
Biomass fuel exposure
Yes 242 33 13.64 <0.0001
No 2158 127 5.89
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COPD is a common health problem with increasing prevalence
all over the world. It is important to know and evaluate the
burden of this disease in our community. Although there is a
considerable healthcare demand, COPD is still under-
diagnosed, inadequately evaluated and inadequately treated.The prevalence of COPD in our study was 6.7% which is in
agreement with studies done in Asia–pacific countries specially
in Vietnam [13]. Also in a Jordanian study using the latest
GOLD criteria 8% were found to be with COPD [14]. In an
Egyptian study done by Tageldin et al., the prevalence of
COPD in the general population using the GOLD clinical def-
inition of symptomatic COPD was 3.6 [15]. However, their
Prevalence of COPD 33case definition of COPD was smokers (P10 pack-years) who
had symptoms of COPD or were already diagnosed by their
physicians. The results between studies from populations,
methodology, and case definition were very different. Our
study is considered a new field, based on the epidemiological
data of COPD in a developing country.
Our data revealed that the prevalence of COPD among
males was higher than among females, 7.04 versus 5.79, old
age >60 than <60 as 9.2 versus 7.7 and X smoker 16.3, cur-
rent smoker 8.6 versus nonsmoker 2.8 and this is in concor-
dance with the study done in Japan [16]. There is a great
variation in studies that report the prevalence of comorbidity
among COPD cases, our study found that hypertension was
present in 15%, diabetes 31%, ischemic heart diseases 24%
which is in agreement with Antonelli et al. [17]. Reflux was
reported in 75% near results was found with Casanova et al.
who found gastro esophageal reflux disease in 62% [18].
Depression was found in 10.5% based on history or medica-
tion usage which is less compared to another study which
mainly researched on depression among COPD using specified
depression scales and found it to be 72% [19].
We found a history of dyspnea 93%, productive cough
76%, wheezy chest 52% and 68% of CAT scoring >10 to
be strongly associated with the presence of COPD with statis-
tically significant difference versus not confirmed cases. And
this is in agreement with that of Shahab et al., and Former
[20,21]. Very few cases were diagnosed COPD while CAT scor-
ing positive either less or more than 10 as this is related to
other causes than COPD such as heart diseases, occupational
role and recurrent chest infection.
In our study the prevalence of COPD among population in
rural area was 6.3 versus 7.6 in urban area without significant
difference this is in disagreement with a chinese study with an
overall prevalence of COPD in rural and urban areas being
9.4%, with a significantly higher prevalence of COPD in rural
than in urban (12.0% versus 7.4%, P, 0.01) and this may be
related to different population numbers of the study [22].
The prevalence of COPD among biomass fuel exposure was
13.6% most of them were females in the rural area using wood,
agricultural crop residues, and associated with poor kitchen
ventilation with a known risk factor for COPD as leading to
greater destruction of airway and parenchyma more than
cigarette with more chest symptoms. This is in agreement with
that of Hu, et al. [23].
Previously diagnosed COPD 7.5% was found in our study,
which indicates underuse of the important diagnostic tool of
spirometry in our community. There is a near finding reported
in a Japanese trial, 9.4% of cases with airflow limitation
reported in a previous diagnosis of COPD [24]. Tunisia with
3.5% had diagnosed COPD [25], while in Sweden 29% had
previously diagnosed lung disorders [26].
According to GOLD 2009 [27] our results revealed that
stage 1 disease was present in 12 cases (7.5%), stage 2 was in
86 cases (53.7%), stage 3 was in 39 cases (24.3%) and stage
4 was in 23 cases (14.3%) which are in concordance with those
of Al Omari et al., who found that 19% had a mild disease and
57 had a moderate disease [14]. In MENA region study [28]
COPD was detected at a late stage which is in agreement with
our study when using GOLD 2011 [29] we found 25% of cases
were in stage D when firstly diagnosed.
Limitations of our study including diagnosis of COPD
cases were based on a fixed ratio of FEV1/FVC<70% accord-ing to GOLD criteria. It under measures the prevalence in
young adults and over measures it among old persons.
Although, more studies used the fixed ratio because it is easily
applicable [30]. A second limitation is in not using the modified
medical research council assessment for a smooth and easily
applicable questionnaire. Also exacerbation history or hospital
admission for complete data about recent staging of COPD
according to GOLD 2011 was not asked as our goal was to
estimate the prevalence in our community.Conclusion
Prevalence of COPD in our locality was 6.6% with high rates
among x and current smokers, males more than females and in
those exposed to biomass fuels. Using CAT scoring as a case-
finding tool may help to identify people who need spirometry
for a possible diagnosis of COPD.
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